Galenica AG engages in the provision of health care. The company is headquartered in Bern, Bern and currently employs 6,125 full-time employees. The company went IPO on 2017-04-07. The firm's business i divided into three business sectors: Retail, Products & Brands, and Services. The firm manages a locally established pharmacies network in Switzerland. The company develops and distributes its own product portfolio, as well as cooperates with a range of business partners, such as Pierre Fabre, Ales Groupe and Vitor Consumer Health for marketing and distribution of such brands as Perskindol, Triofan, A-Derma, Lierac, Phyto, Anti-Brumm and Algifor. Galenica Sante's Services business sector is responsible for management of such logistics sector companies as Galexis, Unione Farmaceutica Distribuzione, Alloga and Medifilm.
Follow-Up Questions
What is the price performance of GALNF stock?
The current price of GALNF is $0, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Galenica AG?
Galenica AG belongs to Health Care industry and the sector is Health Care
What is Galenica AG market cap?
Galenica AG's current market cap is $0
Is Galenica AG a buy, sell, or hold?
According to wall street analysts, 6 analysts have made analyst ratings for Galenica AG, including 2 strong buy, 4 buy, 6 hold, 0 sell, and 2 strong sell
